Skip to main content
Equibles

Intellectus Partners, LLC

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1677253 SAN FRANCISCO, CA
Back to NTLA Full portfolio

Position in NTLA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$925,101
+$226,732 QoQ
Shares Held
54,675
+0.4% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#129
of 329 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Intellectus Partners, LLC holds $12,754,708 across 9 Biotechnology names. NTLA ranks #5 (7.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABCL
AbCellera Biologics Inc.
 551,583 $4,329,926
2 CORT
Corcept Therapeutics Inc
 28,000 $2,434,600
3 REGN
Regeneron Pharmaceuticals, Inc.
 2,696 $1,681,063
4 NUVB
Nuvation Bio Inc.
 293,417 $1,666,608
5 NTLA
Intellia Therapeutics, Inc.
This page 		54,675 $925,101
6 IOVA
Iovance Biotherapeutics, Inc.
 151,846 $631,679
7 RLAY
Relay Therapeutics, Inc.
 20,225 $378,409
8 NKTR
Nektar Therapeutics
 5,400 $376,974

All Filings in NTLA

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $925,101 54,675
2026-03-31 $698,369 54,475
2025-12-31 $459,613 51,125
2025-09-30 $1,502,058 86,975
2025-06-30 $806,445 85,975
2025-03-31 $588,885 82,825
2024-12-31 $868,961 74,525
2024-09-30 $1,208,853 58,825
2024-06-30 $1,303,075 58,225
2024-03-31 $1,568,070 57,000
2023-12-31 $1,696,768 55,650
2023-09-30 $1,604,715 50,750
2023-06-30 $2,096,092 51,400
2023-03-31 $1,724,296 46,265
2022-12-31 $1,593,251 45,665
2022-09-30 $2,348,361 41,965
2022-06-30 $2,237,326 43,225
2022-03-31 $3,230,181 44,450
2021-12-31 $5,619,356 47,525
2021-09-30 $6,834,942 50,950
2021-06-30 $7,876,921 48,650
2021-03-31 $4,606,209 71,625
2020-12-31 $3,586,320 65,925
2020-09-30 $907,522 45,650